These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35360864)

  • 1. Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape.
    Hong-Bin S; Wan-Jun Y; Chen-Hui D; Xiao-Jie Y; Shen-Song L; Peng Z
    Front Genet; 2022; 13():816460. PubMed ID: 35360864
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
    Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
    J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
    Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
    Front Genet; 2022; 13():890641. PubMed ID: 35860468
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic Signatures of Metabolic Genes and Metabolism-Related Long Non-coding RNAs Accurately Predict Overall Survival for Osteosarcoma Patients.
    Chao-Yang G; Rong T; Yong-Qiang S; Tai-Cong L; Kai-Sheng Z; Wei N; Hai-Hong Z
    Front Cell Dev Biol; 2021; 9():644220. PubMed ID: 33708772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients.
    Ni S; Hong J; Li W; Ye M; Li J
    Cancer Med; 2023 Feb; 12(4):5009-5024. PubMed ID: 36129020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
    Yao J; Chen X; Liu X; Li R; Zhou X; Qu Y
    Cancer Cell Int; 2021 Jul; 21(1):340. PubMed ID: 34217273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
    Front Genet; 2021; 12():682082. PubMed ID: 34745200
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy.
    Ma J; Zhang M; Yu J
    Front Oncol; 2022; 12():899925. PubMed ID: 35860577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
    Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
    Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 12. An Immune-Related Long Non-Coding RNA Signature to Predict the Prognosis of Ewing's Sarcoma Based on a Machine Learning Iterative Lasso Regression.
    Ren EH; Deng YJ; Yuan WH; Zhang GZ; Wu ZL; Li CY; Xie QQ
    Front Cell Dev Biol; 2021; 9():651593. PubMed ID: 34124041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Prognostic Ferroptosis-Related lncRNA Signature Associated with Immune Landscape in Invasive Breast Cancer.
    Shen S; Yang D; Yang Y; Chen Y; Xiong J; Hu X
    Dis Markers; 2022; 2022():9168556. PubMed ID: 35359880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
    Yang L; Liu J; Liu S
    BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
    Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
    Hong J; Wang X; Yu L; Li J; Hu H; Mao W
    J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
    Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
    Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.